Bottom line
What is QNZRX's expense ratio?
QNZRX's expense ratio is 3.17%, or about $317 a year on every $10,000 invested. That is more expensive than 99% of large blend funds we track (median 0.83%).
Updated Apr 28, 2026
QNZRX fee table
| Net expense ratio | 3.17% |
|---|---|
| Gross expense ratio | 3.68% |
| Management fee | 1.05% |
| 12b-1 (distribution) fee | 0% |
| Other expenses | 2.6% |
| Acquired fund fees | 0.03% |
| Fee waiver / reimbursement | -0.51% |
Source: Fund prospectus fee table, filed Apr 28, 2026
What QNZRX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| QNZRX | $320 | $1,079 | $1,859 | $3,900 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 3.17% expense ratio costs roughly $146,000 in lost growth, versus about $46,700 for the median large blend fund (0.83%).